Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aaacf277d1ca555b6a99ad72dec179b3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eeb749183265c8ee5828689a15b225a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb63a697ee0b6592b546464f07dde8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcfae040c4cc6f896347015f5addbff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93b78845a474be75f7f35850f1439fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9da3069bde290eddbbad6bbf9118e753 |
publicationDate |
2008-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1928425-A1 |
titleOfInvention |
Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
abstract |
The present invention relates to improved pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an HMG-CoA reductase inhibitor, and more particularly Fluvastatin, Atorvastatin or salts thereof in combination with a linear sulphated polysaccharide such as Carrageenan and a method for the preparation thereof. |
priorityDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |